The private hospital group presented on September 17, 2026 its new strategic roadmap, which follows the previous « Yes We Care 25 » plan and sets directions with a 2030 horizon.
Ramsay Santé indicates that « Connecting Care 2030 » builds on the transformation achieved through the execution of the previous « Yes We Care 25 » plan. The strategy rests on five pillars designed to support operational and financial performance, with everything anchored in what the group describes as medical excellence and its ambition to deliver quality care.
The group presents this plan as a trajectory oriented toward revenue growth and progressive margin improvement, relying on an investment policy described as disciplined, aimed at strengthening its platform, supporting innovation and investing in the future of healthcare.
3% annual growth targeted by 2029 horizon
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The group associates several financial benchmarks with this roadmap. It targets revenue growth of approximately 3.0% per year and progressive improvement in EBITDA margin by 2029.
Ramsay Santé also mentions the continuation of its debt reduction, with an objective concerning the net debt ratio relative to EBITDA (pre-IFRS).
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 3 981 millions d'euros
Quarterly revenue: 3 981 millions d'euros
Revenue growth: 3,1 %
EBITDA: 460,4 millions d'euros
EBITDA margin: 11,6 %
Net income: -27,9 millions d'euros
Free cash flow: 295 millions d'euros
Risks mentioned
Risques liés aux financements publics inférieurs à l'inflation des coûts.
Impact de la grève des médecins français sur les admissions.
Pression sur les marges en raison de l'inflation des coûts de personnel.
Opportunities identified
Croissance continue en Suède grâce à des volumes supplémentaires liés à la reprise des centres d'urgences.
Contribution positive du nouveau contrat St Göran.
Dynamique favorable observée à la fin du trimestre.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
